Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-05-07

Clinical Trial Update: Lifestyle Modification and Liraglutide [Phase 4]

View source ↗

Summary

Phase 4 trial investigating lifestyle modification with liraglutide in obesity completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • liraglutide (liraglutide)

Snippet

Sponsor: University of Pennsylvania | Conditions: Obesity | Phase 4 | Status: COMPLETED | Results posted: 2019-05-07